UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Optimizing Healthcare Expenditure for Spinal Cord Stimulation in Italy: The Value of Battery Longevity Improvement and a Direct-to-Implant Approach

Journal of health economics and outcomes research (Online), 2024-05, Vol.11 (1), p.149-156

2024

Volltextzugriff (PDF)

Workforce requirements for comprehensive ischaemic stroke care in a developing country: the case of Saudi Arabia

Human resources for health, 2019-12, Vol.17 (1), p.90-9, Article 90

2019

Volltextzugriff (PDF)

Methodological issues in the economic analysis of cancer treatments

European journal of cancer (1990), 2006-11, Vol.42 (17), p.2867-2875

2006

Volltextzugriff (PDF)

Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation

BMC cardiovascular disorders, 2021-03, Vol.21 (1), p.160-160, Article 160

2021

Volltextzugriff (PDF)

Intrinsic properties of medical devices: considerations for economic evaluation

Expert review of pharmacoeconomics & outcomes research, 2019-11, Vol.19 (6), p.619-626

2019

Volltextzugriff (PDF)

Are Medical Device Characteristics Included in HTA Methods Guidelines and Reports? A Brief Review

Applied health economics and health policy, 2024-09, Vol.22 (5), p.653-664

2024

Volltextzugriff (PDF)

Economic Implications of Longer Battery Longevity of Cardiac Resynchronization Therapy Defibrillator Devices in the United States

Journal of cardiac failure, 2019-08, Vol.25 (8), p.S167-S167

2019

Volltextzugriff (PDF)

The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease

Journal of neurology, 2014-01, Vol.261 (1), p.106-116

2014

Volltextzugriff (PDF)

Cost-effectiveness of 4 mg dibotermin alfa/absorbable collagen sponge versus iliac crest bone graft for lumbar degenerative disc disease in the United Kingdom

Journal of medical economics, 2022-12, Vol.25 (1), p.59-65

2022

Volltextzugriff (PDF)

Differential Target Multiplexed Spinal Cord Stimulation: A UK Cost-Effectiveness Analysis

Neuromodulation (Malden, Mass.), 2024-07, Vol.27 (5), p.908-915

2024

Volltextzugriff (PDF)

An Epidemiological Model for First Stroke in Saudi Arabia

Journal of stroke and cerebrovascular diseases, 2020-01, Vol.29 (1), p.104465-104465, Article 104465

2020

Volltextzugriff (PDF)

Optimizing Healthcare Expenditure for Spinal Cord Stimulation in Italy: The Value of Battery Longevity Improvement and a Direct-to-Implant Approach

Journal of health economics and outcomes research (Online), 2024-05, p.149-156

2024

Volltextzugriff (PDF)

Option appraisal of population-based colorectal cancer screening programmes in England

Gut, 2007-05, Vol.56 (5), p.677-684

2007

Volltextzugriff (PDF)

Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection

Journal of medical economics, 2018-03, Vol.21 (3), p.294-300

2018

Volltextzugriff (PDF)

Resource Use and Cost of Subcutaneous Nerve Stimulation Versus Optimized Medical Management in Patients With Failed Back Surgery Syndrome: An Analysis of the SubQStim Study

Neuromodulation (Malden, Mass.), 2021-08, Vol.24 (6), p.1033-1041

2021

Volltextzugriff (PDF)

Abstract 12995: Prevalence and Incidence of Atrial Fibrillation in a Population Implanted With Cardiac Resynchronization Therapy Devices Implanted for at Least 30 Days: Evidence From a Prospective Clinical Trial

Circulation (New York, N.Y.), 2016-11, Vol.134 (Suppl_1 Suppl 1), p.A12995-A12995

2016

Volltextzugriff (PDF)

Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation

Europace (London, England), 2014-05, Vol.16 (5), p.652-659

2014

Volltextzugriff (PDF)

A national economic and clinical model for ischemic stroke care development in Saudi Arabia: A call for change

International journal of stroke, 2019-10, Vol.14 (8), p.835-842

2019

Volltextzugriff (PDF)

Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries

European heart journal. Quality of care & clinical outcomes, 2024-01, Vol.10 (1), p.25-35

2024

Volltextzugriff (PDF)

Reply to: Brough CEP, Haycox A. Resource Use In Rectifying Pacemaker Complications. Journal of Medical Economics 2018. doi: 10.1080/13696998.2017.1423075

Journal of medical economics, 2018-03, Vol.21 (3), p.310-311

2018

Volltextzugriff (PDF)

Global health resource utilization associated with pacemaker complications

Journal of medical economics, 2017-07, Vol.20 (7), p.732-739

2017

Volltextzugriff (PDF)

Abstract 16318: Clinical and Economic Value of Maximizing Response to Cardiac Resynchronization Therapy (CRT): Evidence From 5 Randomized Controlled Trials

Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2)

2014

Volltextzugriff (PDF)

Financial impact of adopting implantable loop recorder diagnostic for unexplained syncope compared with conventional diagnostic pathway in Portugal

BMC cardiovascular disorders, 2014-05, Vol.14 (1), p.63-63, Article 63

2014

Volltextzugriff (PDF)

Methodological issues in the economic analysis of cancer treatments : Pharmacoeconomics

European journal of cancer (1990), 2006, Vol.42 (17), p.2867-2875

2006

Volltextzugriff (PDF)

Morphogen regulation of stem cell plasticity in intestinal regeneration and carcinogenesis

Developmental dynamics, 2022-01, Vol.251 (1), p.61-74

2022

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Optimizing Healthcare Expenditure for Spinal Cord Stimulation in Italy: The Value of Battery Longevity Improvement and a Direct-to-Implant Approach

Workforce requirements for comprehensive ischaemic stroke care in a developing country: the case of Saudi Arabia

Methodological issues in the economic analysis of cancer treatments

Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation

Intrinsic properties of medical devices: considerations for economic evaluation

Are Medical Device Characteristics Included in HTA Methods Guidelines and Reports? A Brief Review

Economic Implications of Longer Battery Longevity of Cardiac Resynchronization Therapy Defibrillator Devices in the United States

The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease

Cost-effectiveness of 4 mg dibotermin alfa/absorbable collagen sponge versus iliac crest bone graft for lumbar degenerative disc disease in the United Kingdom

Differential Target Multiplexed Spinal Cord Stimulation: A UK Cost-Effectiveness Analysis

An Epidemiological Model for First Stroke in Saudi Arabia

Optimizing Healthcare Expenditure for Spinal Cord Stimulation in Italy: The Value of Battery Longevity Improvement and a Direct-to-Implant Approach

Option appraisal of population-based colorectal cancer screening programmes in England

Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection

Resource Use and Cost of Subcutaneous Nerve Stimulation Versus Optimized Medical Management in Patients With Failed Back Surgery Syndrome: An Analysis of the SubQStim Study

Abstract 12995: Prevalence and Incidence of Atrial Fibrillation in a Population Implanted With Cardiac Resynchronization Therapy Devices Implanted for at Least 30 Days: Evidence From a Prospective Clinical Trial

Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation

A national economic and clinical model for ischemic stroke care development in Saudi Arabia: A call for change

Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries

Reply to: Brough CEP, Haycox A. Resource Use In Rectifying Pacemaker Complications. Journal of Medical Economics 2018. doi: 10.1080/13696998.2017.1423075

Global health resource utilization associated with pacemaker complications

Abstract 16318: Clinical and Economic Value of Maximizing Response to Cardiac Resynchronization Therapy (CRT): Evidence From 5 Randomized Controlled Trials

Financial impact of adopting implantable loop recorder diagnostic for unexplained syncope compared with conventional diagnostic pathway in Portugal

Methodological issues in the economic analysis of cancer treatments : Pharmacoeconomics

Morphogen regulation of stem cell plasticity in intestinal regeneration and carcinogenesis

Suchergebnisse filtern